CA2935207C - Pharmaceutically relevant aromatic-cationic peptides - Google Patents

Pharmaceutically relevant aromatic-cationic peptides Download PDF

Info

Publication number
CA2935207C
CA2935207C CA2935207A CA2935207A CA2935207C CA 2935207 C CA2935207 C CA 2935207C CA 2935207 A CA2935207 A CA 2935207A CA 2935207 A CA2935207 A CA 2935207A CA 2935207 C CA2935207 C CA 2935207C
Authority
CA
Canada
Prior art keywords
acid
compound
formula
hexafluorophosphate
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2935207A
Other languages
English (en)
French (fr)
Other versions
CA2935207A1 (en
Inventor
D. Travis Wilson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Stealth Biotherapeutics Inc
Original Assignee
Stealth Biotherapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stealth Biotherapeutics Inc filed Critical Stealth Biotherapeutics Inc
Publication of CA2935207A1 publication Critical patent/CA2935207A1/en
Application granted granted Critical
Publication of CA2935207C publication Critical patent/CA2935207C/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1019Tetrapeptides with the first amino acid being basic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/02General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length in solution

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA2935207A 2013-12-27 2014-12-23 Pharmaceutically relevant aromatic-cationic peptides Active CA2935207C (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201361921376P 2013-12-27 2013-12-27
US61/921,376 2013-12-27
US201461947261P 2014-03-03 2014-03-03
US61/947,261 2014-03-03
PCT/US2014/072264 WO2015100376A1 (en) 2013-12-27 2014-12-23 Pharmaceutically relevant aromatic-cationic peptides

Publications (2)

Publication Number Publication Date
CA2935207A1 CA2935207A1 (en) 2015-07-02
CA2935207C true CA2935207C (en) 2022-06-21

Family

ID=53479676

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2935207A Active CA2935207C (en) 2013-12-27 2014-12-23 Pharmaceutically relevant aromatic-cationic peptides

Country Status (6)

Country Link
US (2) US10221213B2 (enExample)
EP (1) EP3087093B1 (enExample)
JP (1) JP6626446B2 (enExample)
CN (2) CN112457368A (enExample)
CA (1) CA2935207C (enExample)
WO (1) WO2015100376A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015100376A1 (en) * 2013-12-27 2015-07-02 Stealth Peptides International, Inc. Pharmaceutically relevant aromatic-cationic peptides
US10125164B2 (en) 2014-06-25 2018-11-13 Flamma S.P.A. Process for preparing D-arginyl-2,6-dimethyl-L-tyrosyl-L-lysyl-L-phenylalaninamide
EP3160985B1 (en) * 2014-06-30 2021-07-28 Flamma S.P.A. Process for the production of d-arginyl-2,6-dimethyl-l-tyrosyl-l-lysyl-l-phenylalaninamide
EP3800192A1 (en) * 2015-03-06 2021-04-07 Stealth Biotherapeutics Corp Processes for preparing pharmaceutically relevant peptides
CN109563131A (zh) 2016-04-11 2019-04-02 卡诺有限责任公司 手性肽
CN110087667A (zh) * 2016-08-16 2019-08-02 隐形生物治疗公司 Elamipretide的基于N-羧基酸酐的规模合成
US11034724B2 (en) 2017-04-05 2021-06-15 Stealth Biotherapeutics Corp. Crystalline salt forms of Boc-D-Arg-DMT-Lys-(Boc)-Phe-NH2
US20200361987A1 (en) * 2017-11-15 2020-11-19 Stealth Biotherapeutics Corp. Deuterated tetrapeptides that target mitochondria
US10676506B2 (en) 2018-01-26 2020-06-09 Stealth Biotherapeutics Corp. Crystalline bis- and tris-hydrochloride salt of elamipretide
CN108929371A (zh) * 2018-08-02 2018-12-04 哈尔滨师范大学 一种Phakellistatin13直链衍生物、其制备办法及用途

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2067000C1 (ru) 1994-06-29 1996-09-27 Владислав Исакович Дейгин Пептид и способ его получения
US6248716B1 (en) * 1995-06-27 2001-06-19 Immunotech Developments Inc. Peptide, a method for its preparation and a pharmaceutical composition containing the peptide
US20030069231A1 (en) * 1999-10-12 2003-04-10 Klaus Rudolf Modified aminoacids, pharmaceuticals containing these compounds and method for their production
AU2001275525B2 (en) 2000-06-14 2007-04-26 Medarex, Inc. Tripeptide prodrug compounds
JP5374162B2 (ja) 2006-02-22 2013-12-25 エジソン ファーマシューティカルズ, インコーポレイテッド ミトコンドリア病および他の症状の処置のためのレドックス活性化治療の側鎖変異体およびエネルギーバイオマーカーの調節
US20070213505A1 (en) * 2006-03-08 2007-09-13 David Epstein Solution Synthesis of Peptide Cell Growth Stimulators
WO2011116007A1 (en) 2010-03-15 2011-09-22 Stealth Peptides International, Inc. Combination therapies using cyclosporine and aromatic cationic peptides
HK1197028A1 (en) * 2011-06-14 2015-01-02 Stealth Peptides International, Inc. Aromatic-cationic peptides and uses of same
CN104244964A (zh) * 2012-02-22 2014-12-24 康肽德生物医药技术有限公司 用于预防或治疗眼科病状的方法和组合物
WO2014088631A1 (en) 2012-12-06 2014-06-12 Stealth Peptides International, Inc. Peptide therapeutics and methods for using same
JP2016539931A (ja) 2013-10-23 2016-12-22 株式会社カネカ テトラペプチド化合物及びその製造方法
WO2015100376A1 (en) * 2013-12-27 2015-07-02 Stealth Peptides International, Inc. Pharmaceutically relevant aromatic-cationic peptides
EP3114136A4 (en) * 2014-03-03 2017-11-01 Stealth BioTherapeutics Corp Pharmaceutically relevant aromatic-cationic peptides

Also Published As

Publication number Publication date
EP3087093A1 (en) 2016-11-02
CN106132984B (zh) 2020-12-08
US10696716B2 (en) 2020-06-30
WO2015100376A1 (en) 2015-07-02
US20200024308A1 (en) 2020-01-23
US10221213B2 (en) 2019-03-05
EP3087093B1 (en) 2021-11-10
US20160340389A1 (en) 2016-11-24
CA2935207A1 (en) 2015-07-02
CN112457368A (zh) 2021-03-09
CN106132984A (zh) 2016-11-16
JP2017502956A (ja) 2017-01-26
JP6626446B2 (ja) 2019-12-25
EP3087093A4 (en) 2017-09-27

Similar Documents

Publication Publication Date Title
CA2935207C (en) Pharmaceutically relevant aromatic-cationic peptides
CA2942143A1 (en) Pharmaceutically relevant aromatic-cationic peptides and methods of generating the same
US12331072B2 (en) Deprotection method and resin removal method in solid-phase reaction for peptide compound or amide compound, and method for producing peptide compound
US12037414B2 (en) Processes for preparing pharmaceutically relevant peptides
CA2733790A1 (en) Macrocyclic compounds for inhibition of tumor necrosis factor alpha
CA2863599C (en) Process for preparing 4-amino-5-biphenyl-4-yl-2-hydroxymethyl-2-methyl-pentanoic acid compounds
HK1230631B (en) Pharmaceutically relevant aromatic-cationic peptides
HU185230B (en) Process for producing pharmacologically active encephaline analogous peptides
AU2012234680A1 (en) Prodrugs of D-isoglutamyl-[D/L]-tryptophan
HK40049251A (en) Processes for preparing pharmaceutically relevant peptides
HK1248604B (en) Processes for preparing pharmaceutically relevant peptides
HK1248604A1 (en) Processes for preparing pharmaceutically relevant peptides
CA3024324C (en) Seco macrolide compounds
MXPA05005969A (es) Proceso para la preparacion de compuestos peptidos biciclicos.

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20190930

EEER Examination request

Effective date: 20190930